Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 23;37(11):2320–2326. doi: 10.1038/s41433-022-02342-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 2 — Based on ANCOVA model including baseline CFS score and Study as covariates. Missing data at day 28 has been replaced by the last post-treatment observation available (LOCF method). Low-dose regimen: CsA CE 0.1% BID or 0.05% QID, High-dose regimen: CsA CE 0.1% QID. ANCOVA analysis of covariance, BID twice daily, CFS corneal fluorescein staining, CsA CE cyclosporine A cationic ophthalmic emulsion, LOCF last observation carried forward, QID 4 times daily, SD standard deviation.